| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/02/2005 | US6924362 Monoclonal antibodies specific for the E2 glycoprotein of hepatitic C virus and their use in the diagnosis, treatment, and prevention of hepatitis C |
| 08/02/2005 | US6924361 Phosphopeptide-specific antibodies that are activity specific; methods of production and antibody uses |
| 08/02/2005 | US6924360 Antitumor agents |
| 08/02/2005 | US6924359 Neovascular-targeted immunoconjugates |
| 08/02/2005 | US6924357 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy |
| 08/02/2005 | US6924356 Human protein HHEPU32 |
| 08/02/2005 | US6924266 NTP-peptides and method for removal of tumors |
| 08/02/2005 | US6924126 Cloning, expression and characterization of the SPG4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 08/02/2005 | US6924125 Expression of heterologous multi-domain proteins in yeast |
| 08/02/2005 | US6924121 Sperm specific proteins |
| 08/02/2005 | US6924110 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 08/02/2005 | US6924095 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 08/02/2005 | US6923964 amyloid fibrils; for preventing/treating amyloid diseases/Alzheimer's disease |
| 08/02/2005 | CA2078539C Process for producing humanized chimera antibody |
| 07/28/2005 | WO2005068622A2 Mixtures of binding proteins |
| 07/28/2005 | WO2005068619A1 Generation of specific adhesion in gram-negative bacteria by means of anchoring immunoglobulin single domains on their surface with autotransporters |
| 07/28/2005 | WO2005068504A1 Inflammatory cytokine inhibitor |
| 07/28/2005 | WO2005068503A2 M-csf-specific monoclonal antibody and uses thereof |
| 07/28/2005 | WO2005067980A2 Design of therapeutics and therapeutics |
| 07/28/2005 | WO2005067971A1 Drug for preventing and treating arteriosclerosis |
| 07/28/2005 | WO2005067708A2 Zebrafish model for autoimmune diseases |
| 07/28/2005 | WO2005067648A2 Multiplex spatial profiling of gene expression |
| 07/28/2005 | WO2005067620A2 ANTIBODIES TO MAdCAM |
| 07/28/2005 | WO2005067477A2 Anti-human lymphotoxin alpha antibodies, compositions, methods and uses |
| 07/28/2005 | WO2005051983A3 Oligomeric complexe formation of recombinant multi subunit chimeric polypeptides |
| 07/28/2005 | WO2005047328A3 Antibodies against secretoryleukocyte protease inhibitor |
| 07/28/2005 | WO2005047325A3 Monkey immunoglobulin sequences |
| 07/28/2005 | WO2005042581A3 Modified anti-cd52 antibody |
| 07/28/2005 | WO2005037867B1 ALTERATION OF Fc-FUSION PROTEIN SERUM HALF-LIVES BY MUTAGENESIS OF POSITIONS 250, 314 AND/OR 428 OF THE HEAVY CHAIN CONSTANT REGION OF IG |
| 07/28/2005 | WO2005030931A3 Altering a b cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent |
| 07/28/2005 | WO2005025516A3 Monoclonal antibodies specific for conformational epitopes of prefibrillar aggregates |
| 07/28/2005 | WO2005017163A3 Phenotypic knockout of cell-surface proteins |
| 07/28/2005 | WO2005014650A3 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 07/28/2005 | WO2005004793A3 Compositions and methods for treating coagulation related disorders |
| 07/28/2005 | WO2005001421A3 Improved piezoimmunosensor |
| 07/28/2005 | WO2005001033A3 Tolerance induction and maintenance in hematopoietic stem cell allografts |
| 07/28/2005 | WO2004110362A3 Immunotherapeutics for biodefense |
| 07/28/2005 | WO2004108895A3 Humanized antibodies that recognize beta amyloid peptide |
| 07/28/2005 | WO2004050683A8 Antibodies directed to tumor necrosis factor and uses thereof |
| 07/28/2005 | WO2004031206A8 Products for regulating the degradation of collagen and methods for indentifying same |
| 07/28/2005 | WO2003099196A3 Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency |
| 07/28/2005 | WO2003072035A8 Compositions and methods for the treatment of immune related diseases |
| 07/28/2005 | WO2002081497A3 αξβ3 INTEGRIN-BINDING POLYPEPTIDE MONOBODIES AND THEIR USE |
| 07/28/2005 | US20050166274 Compositions and methods for the diagnosis and treatment of tumor |
| 07/28/2005 | US20050165222 Using protease inhibitor to reduce concentration of protein a impurities during antibody elution/purification; enzyme inhibitors |
| 07/28/2005 | US20050165219 Related to the thymic stromal cotransporter subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity |
| 07/28/2005 | US20050164984 Chondroitin synthase gene and methods of making and using same |
| 07/28/2005 | US20050164965 DNA or RNA having a modified backbone or base and a section that hybridizes to an EphrinB2 or EphB4 transcript causing gene expression inhibition; antineoplastic and antiproliferative agents can be synergistically administered with a second agent |
| 07/28/2005 | US20050164387 Propagating lymphocytic cells without using large excesses of peripheral blood mononuclear cells (PBMC) or epstein barr virally-transformed lymphoblastoid cells (LCL); immunotherapy |
| 07/28/2005 | US20050164352 Immunoglobulin interleukin fusion for activating lymphoid precursor cells; treatment and prevention of infection |
| 07/28/2005 | US20050164314 Antibodies that recognize and bind phosphorylated human androgen receptor and methods of using same |
| 07/28/2005 | US20050164313 Methods and compositions for the detection of cervical cancer |
| 07/28/2005 | US20050164312 IL1-beta: a new target for myeloma therapy |
| 07/28/2005 | US20050164309 Human prolactin-binding protein either isolated from human serum or milk or produced recombinantly, used to inhibit Nb2 cells and to diagnose disease or conditions associated with somatolactogenic function |
| 07/28/2005 | US20050164303 Specific-C-peptide assay method |
| 07/28/2005 | US20050164302 Analyzing and typing monoclonal proteins by capillary electrophoresis and immunodisplacement |
| 07/28/2005 | US20050164291 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/28/2005 | US20050164284 Immunoglobulin composition for detection of cell death regulatory proteins; diagnosing cardiovascular, tumor, diabetic and nervous system disorders |
| 07/28/2005 | US20050164279 Secreted and transmembrane polypetides and nucleic acids encoding the same |
| 07/28/2005 | US20050164266 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/28/2005 | US20050164263 identification of amino acid sequences and proteins related to MAP/ERK subfamily; gene chip; transgenic nonhuman animal; nucleic acid vector; expression in larynx epithelium, Wilms' tumors of the kidney, pancreas adenocarcinomas, fetal brain, and hippocampus; models for human therapeutic targets |
| 07/28/2005 | US20050164247 isolated nucleic acid molecule wherein CD4+T cells over-expressing said nucleic acid sequence exhibits a reduction in CD3 and CD28 mediated T-cell proliferation; vector and host cell transformed with said nucleic acid |
| 07/28/2005 | US20050164232 Reg-like protein |
| 07/28/2005 | US20050164216 Methods and compositions for selectively cleaving DNA containing duplex nucleic acids in a complex nucleic acid mixture, and nuclease compositions for use in practicing the same |
| 07/28/2005 | US20050164202 Nucleotide sequences coding junctophilin-like polypeptides (JPL) to prevent ad treat cell proliferative disorders; antitumor agents; anticarcinogenic agents; tissue targeted therapy; immunotherapeutics |
| 07/28/2005 | US20050164180 Phage diplay libraries of human vh fragments |
| 07/28/2005 | US20050164178 Starch branching enzyme |
| 07/28/2005 | US20050164166 Expression vector comprising nucleotide sequences coding immunoglobulin-envelope protein fusion; immunotherapy; viricides |
| 07/28/2005 | US20050164163 Helicase inhibitors; enzyme inhibitor; viricides agent; mimetics |
| 07/28/2005 | US20050163804 Containing transcriptional units which encode a signal sequence of one flavivirus and an immunogenic flavivirus antigen of a second flavivirus; Japanese encephalitis virus (JEV), West Nile virus (WNV) or related flaviviruses |
| 07/28/2005 | US20050163788 Prevention and treatment of amyloidogenic disease |
| 07/28/2005 | US20050163786 Compounds and methods for modulating adhesion molecule function |
| 07/28/2005 | US20050163785 affect cell growth by blocking progression of the cell cycle in G2/M and their use in therapy of cancers which express the antigen |
| 07/28/2005 | US20050163783 polypeptide dimers having at least four binding sites and at least two polypeptide chains linked via at least one interchain disulfide linkage; IgG3 hinge domain |
| 07/28/2005 | US20050163782 polypeptide dimers having at least four binding sites and at least two polypeptide chains linked via at least one interchain disulfide linkage; IgG3 hinge domain |
| 07/28/2005 | US20050163781 uses of inhibitors against hypoxia-induced genes for the manufacture of a medicament to prevent and/or to suppress post-operative/post-wounding adhesions formation; peritoneal or pelvic cavities resulting from wound, surgery, infection, inflammation or trauma |
| 07/28/2005 | US20050163780 Administering antagonist of a GP39, selected from an antibody which specifically bind GP39, soluble CD40 and soluble CD40 fusion proteins |
| 07/28/2005 | US20050163779 smooth muscle growth inhibitory composition comprising adipose tissue-specific secretory factor apM1 (adipose most abundant gene transcript 1) as an active ingredient; diagnostic agent comprising an antibody against the adipose tissue-specific secretory factor apM1 |
| 07/28/2005 | US20050163778 Extracorporeal photopheresis in combination with anti-TNF treatment |
| 07/28/2005 | US20050163777 prevention and treatment of cancer as well as immune system diseases and disorders including pre-eclampsia, hypertension, inflammation, asthma, gastrointestinal disorders, anxiety, depression, addiction, or pain; host cell; kits; expression vector |
| 07/28/2005 | US20050163776 Treatment of tse infection |
| 07/28/2005 | US20050163773 Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and activity |
| 07/28/2005 | US20050163772 B7S1: an immune modulator |
| 07/28/2005 | US20050163771 Administering N-acetyl-cysteine; anda compound for reversing a high level of high affinity receptor mediated oxytocin effect; administering compounds for reversing at least two biochemical conditions associated with preterm labor |
| 07/28/2005 | US20050163770 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 07/28/2005 | US20050163769 Chimeric and humanized antibodies to alpha5beta1 integrin that modulate angiogenesis |
| 07/28/2005 | US20050163768 For immunization against cancer of epithelial origin and against small cell lung cancer, immunization against HIV-infections; murine internal image anti-idiotypic antibodies (Ab2) to monoclonal antibodies BR55-2 (Ab1) |
| 07/28/2005 | US20050163767 useful as a diagnostic marker or a drug target for bronchial asthma, chronic obstructive pulmonary disease; isolated antibody which specifically binds to a specific protein belonging to the chitinase family |
| 07/28/2005 | US20050163766 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/28/2005 | US20050163747 Heteromultimeric TNF ligand family members |
| 07/28/2005 | US20050163709 Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes |
| 07/28/2005 | US20050163708 Chimeric antibody with specificity to human B cell surface antigen |
| 07/28/2005 | US20050163707 Radio labelled monoclonal antibody human milk fat globule1, binds selectively to polymorphic epithelial mucin; Taxotere chemotherapeutic agent; administered in combination |
| 07/28/2005 | US20050162187 Programmable I/O element circuit for high speed logic devices |
| 07/28/2005 | US20050161399 LC/MS method of analyzing high molecular weight proteins |
| 07/28/2005 | DE10359189A1 Electrofusion of heterologous cells, useful e.g. for preparing hybridomas and in assisted reproduction, comprises immobilizing different cells close to each other on a carrier then applying an electrical fusion pulse |
| 07/28/2005 | CA2554054A1 Mixtures of binding proteins |
| 07/28/2005 | CA2553807A1 Generation of specific adhesion in gram-negative bacteria by means of anchoring immunoglobulin single domains on their surface with autotransporters |
| 07/28/2005 | CA2552750A1 M-csf-specific monoclonal antibody and uses thereof |
| 07/28/2005 | CA2552523A1 Monoclonal antibodies to mucosal addressin cell adhesion molecule(madcam) |